Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 4, 2013 (13 years ago)

VersaPharm Incorporated

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Discoloration: Ethambutol HCl Tablets 400 mg is being recalled due to a Out of Specification result for description testing for a surface defect of ink.

Cause type: Failed specification

A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.

What was recalled

VersaPharm Incorporated, Ethambutol Hydrochloride Tablets, USP 400 mg 60 tablets, Rx Only, Mfd. for VersaPharm Incorporated Marietta, GA 30065-1509; Mfd. by: West-ward Pharmaceuticals Corp., Eatontown, NJ 07724 NDC 61748-014-06,

Affected NDC 61748-0014-06

Compare with the code on your package — it is the most precise check available.

Drug: Ethambutol

Recalling firm
West-Ward Pharmaceutical Corp.
NDC code
61748-014-06
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-839-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ethambutol recalls

See all
Class II · Moderate risk

Ethambutol HCl active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-660-2015
Class II · Moderate risk

Teva Ethambutol Hydrochloride Tablets

CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were manufactured using unapproved material: the incorrect gelatin excipient than specified in the product formulation.

Terminated Unapproved drug Teva Pharmaceuticals USA NDC 0555-0923-02 D-1092-2014
Class III · Low risk

Ethambutol Hydrochloride Tablets USP

Failed Impurities/Degradation Specifications: This product is being recalled due to an out of specification result for an impurity.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. NDC 68180-281-01 D-346-2014

Other recalls by West-Ward Pharmaceutical Corp.

All 2013 recalls
Class II · Moderate risk

PredniSONE Tablets USP

Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

Terminated Failed specification West-Ward Pharmaceutical NDC 0054-4741-25 D-0008-2017
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).

Terminated Impurity / degradation West-Ward Pharmaceutical Corp. NDC 0641-6028-25 D-1139-2015
Class III · Low risk

Fentanyl Citrate Inj.

Failed Impurities/Degradation Specifications; 12 month stability testing.

Terminated Impurity / degradation West-Ward Pharmaceutical Corporation NDC 0641-6028-25 D-0420-2015